Sensitivity index of antimicrobial agents: A new treatment criteria proposed for rational use of antimicrobials

Indian Journal of Medical Microbiology

Volumn 22, Issue 2, 2004, Pages 107-111

  Achla, P ^a   Sudha, V ^a   Soni, G R ^a   Khare, S ^b   Bhatia, R ^c  

^a National Institute of Biologicals   (India)

^b NATIONAL INSTITUTE OF COMMUNICABLE DISEASES   (India)

^c WHO Regional Office for South East Asia   (India)

Author keywords

Proposed criteria; Rational use of antimicrobials; Sensitivity index

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFALOTIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; NALIDIXIC ACID; NETILMICIN; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; PIPERACILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG USE; ESCHERICHIA COLI; GEOGRAPHICAL VARIATION (SPECIES); NONHUMAN; PRACTICE GUIDELINE; SENSITIVITY ANALYSIS;

EID: 2442480873     PISSN: 02550857     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. National Committee for Clinical Laboratory Standards. Performance standards for Antimicrobial Disk Susceptibility Tests; Approved Standards, 7th ed. 2000,20:1.
2. WHONET5, Microbiology Laboratory Database Software. WHO. Department of Communicable Diseases Surveillance and Response. World Health Organization, CSR/DRS, 1211 Geneva, 27, Switzerland.
3. Gupta V, Yadav A, Joshi RM. Antibiotic resistance pattern in uropathogens. Indian J Med Microbiol 2002;20:96-98.
4. Kumar CSV, Jairam A, Chetan S, Sudesh P, Kapur I, Srikaramallya. Asymptomatic bacteriuria in school going children. Indian J Med Microbiol 2002;20:29-32.
5. Sahm DF, Thornsberry C, Mayfield DC, Jones ME, Karlowsky JA. Multidrug - Resistant Urinary Tract Isolates of Escherichia coli: Prevalence and Patient Demographics in United States in 2000. Antimicrob Agents Chemother 2000;45:1402-1406.
6. European Antimicrobial Resistance Surveillance System. EARSS Newsletter, No.4: 2002.Ed.EARSS Management Team, National Institute of Public Health and the Environment(RIVM, the Netherlands)
7. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, Martinez F, Marrie TJ, Plouffe JF, Ramirez J, Sarosi GA, Torres A, Wilson R, Yu LL, American Thoracic Society. Guidelines for the Management of Adults with Community Acquired Pneumonia. Executive Summary. Am J Respir Crit Care Med 2001;163(7):1730-1754.
8. Adhikari KM, Prabha MR, Baliga S. Ciprofloxacin resistant typhoid with incomplete response to Cefotaxime. JAPI 2002;50:428-29
9. Chogle A R. Multidrug resistant salmonellosis: an escalating problem. JAPI 2002; 50:375-377.
10. Kücükates E, Kocazybeck B. High resistance rate against 15 different antibiotics in aerobic gram-negative bacteria isolates of cardiology intensive care unit patients. Indian J Med Microbiol 2002;20:208-210.
11. Gopal N, Rajeev K. Pattern of multi-drug resistance and phage types in Salmonella enterica subspecies enterica serotype Typhi in Varanasi during 1979-1997. Indian J Med Microbiol 1999;17:97-98.
12. Chaudhary A. In vitro activity of Cefpirome: A new fourth generation Cephalosporin. Indian J Med Microbiol.2003;21:52-53.
13. Sood S, Arti K, Das BK, Seth P. Typhoid Fever Treatment: A Continuing Challenge. Indian J Med Microbiol 1999;17(3):153.
14. Shales DM, Gerding DN, John JF, Craig WA, Bornstein DL, Duncan RA, Eckman MR, Farrer WE, Greene WH, Lorian V, Levy S, McGowan JE, Paul SM, Ruskin J, Tenover FC, Watanakunakorn C. Guidelines for the Prevention of Antimicrobial Resistance in hospitals by Society for Health Care Epidemiology of America and Infectious Disease Society of America Joint Committee on the Prevention of Antimicrobial Resistance (JCPAR). Clin.Infect.Dis.1997;25:584-599.
15. O'Brien TF, Stelling JM. WHONET: Removing obstacles to the full use of information about antimicrobial resistance. Diag Microbiol Infect Dis 1996;25:162-168.